NEK6 has been reported to be a central kinase responsible for the development of castrated tolerant prostate cancer 5, and knocking out NEK6 can reduce clonogenesis, proliferation, cell viability and mitochondrial activity and further increase intracellular reactive oxygen species (ROS) levels. The gene discussed is NEK6; the disease is prostate carcinoma.